Immunome Inc. (IMNM) awards RSUs and 62,500 stock options to CBO
Rhea-AI Filing Summary
Immunome Inc.’s Chief Business Officer, Kinney Horn, received equity compensation awards. On July 23, 2026, Horn was granted 31,250 shares of common stock underlying RSUs and 62,500 employee stock options with a $22.01 exercise price, vesting over time subject to continuous service, with options expiring July 22, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 31,250 shares
Net Buy
2 txns
Insider
Horn Kinney
Role
CHIEF BUSINESS OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F2 | 62,500 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 31,250 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 62,500 shares (Direct);
Common Stock — 31,250 shares (Direct)
Footnotes (2)
- F1. Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date.
- F2. 25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Key Figures
RSU grant: 31,250 shares
Stock option grant: 62,500 options
Option exercise price: $22.01 per share
+3 more
6 metrics
RSU grant
31,250 shares
Common stock underlying RSUs granted to Chief Business Officer on July 23, 2026
Stock option grant
62,500 options
Employee Stock Option (right to buy) granted on July 23, 2026
Option exercise price
$22.01 per share
Conversion or exercise price for the 62,500 stock options
Option expiration date
July 22, 2036
Expiration date of the Employee Stock Option award
RSU vesting rate
25% annually
Portion of RSUs vesting each year on the grant-date anniversary, subject to continuous service
Initial option vesting date
July 23, 2027
25% of option shares vest on this date, subject to continuous service
Key Terms
restricted stock units ("RSUs"), Employee Stock Option (right to buy), vesting, continuous service
4 terms
restricted stock units ("RSUs") financial
"Represents the number of shares of Common Stock underlying restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Employee Stock Option (right to buy) financial
"Security title reported as Employee Stock Option (right to buy)."
vesting financial
"25% of the RSUs will vest and settle annually on each anniversary."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"Vesting is subject to the Reporting Person's continuous service."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Immunome (IMNM) grant to Kinney Horn?
Immunome granted Chief Business Officer Kinney Horn 31,250 RSUs and 62,500 stock options. The RSUs each represent one share of common stock, while the options carry a $22.01 exercise price and separate time-based vesting conditions.
What are the terms of Kinney Horn's RSU grant at Immunome (IMNM)?
Horn’s RSU grant covers 31,250 shares of Immunome common stock. Each RSU converts into one share upon settlement, with 25% of the RSUs vesting and settling annually on each grant-date anniversary, conditioned on Horn’s continuous service through each vesting date.
How do Kinney Horn's Immunome (IMNM) stock options vest?
Horn’s 62,500 stock options vest over time. 25% of the option shares vest on July 23, 2027, and one‑thirty‑sixth of the remaining shares vests monthly thereafter, in each case subject to his continuous service on each vesting date.
What is the exercise price and expiration date of Kinney Horn's Immunome (IMNM) options?
The granted stock options have a $22.01 per share exercise price and expire on July 22, 2036. These are employee stock options to purchase Immunome common stock, exercisable as they vest over the described schedule.
Is Kinney Horn's Form 4 transaction at Immunome (IMNM) a purchase or a grant?
The Form 4 reports grant/award acquisitions, not open‑market purchases or sales. Horn received RSUs and stock options at a reported price of $0.00 per share, reflecting compensatory awards rather than cash transactions in Immunome stock.